Behcet Disease Should Be Considered a Causative Factor of Cerebral Venous Sinus Thrombosis
Behçet disease should be considered an initial causative factor of cerebral venous sinus thrombosis.
Behçet disease should be considered an initial causative factor of cerebral venous sinus thrombosis.
Researchers investigated the characteristics and outcomes of patients with systemic lupus erythematosus-associated thrombotic microangiopathy based on their ADAMTS13 inhibitor profiles.
The aPS/PT antibodies might represent markers of aPL-related pregnancy complications, such as intrauterine grown restriction and preeclampsia.
A clinical trial is underway to assess the safety and efficacy of dabigatran in intermediate-risk pulmonary embolism after completing 72 hours of heparin therapy.
Platinum-based chemotherapy agents for lung cancer may increase the risk for thromboembolism.
Several clinical predictors of pediatric pulmonary embolism have been identified.
An increased prevalence of melanoma has been observed in patients with various immunocompromised conditions.